Vol. XVIII · Free shipping $75+ · Read the collection
Feature · Product Review
glutathione cisplatin

glutathione cisplatin Switchable nanoparticles complexing for circumventing depletion in breast cancer chemotherapy Cisplatin - Group 10: platinum

Cisplatin Group 10: platinum anticancer agents Glutathione depletion sensitizes cisplatin and temozolomide resistant glioma cells in vitro and in vivo Cell Death & Disease Reversal of cisplatin chemotherapy resistance by glutathione resistant copper based nanomedicine via cuproptosis Journal of Materials Chemistry B (RSC Publishing) PDF] Kinetic Study on the Reactions of Platinum Drugs with Glutathione Semantic Scholar

SKU: 104455594 · From equiscorp.hu

4.4
USD27.21 USD68.21

Pay in 4 interest-free payments of $6.80 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Description

NF-B signaling and the NLRP3 inflammasome Chronic inflammation serves as the core driver of declining renal function following AKI and progression to CKD

glutathione cisplatin Switchable nanoparticles complexing for circumventing depletion in breast cancer chemotherapy Cisplatin - Group 10: platinum

The publication fee was supported by Dexlevo Inc

glutathione cisplatin Switchable nanoparticles complexing for circumventing depletion in breast cancer chemotherapy Cisplatin - Group 10: platinum

E.ShadelG

glutathione cisplatin Switchable nanoparticles complexing for circumventing depletion in breast cancer chemotherapy Cisplatin - Group 10: platinum

Biol Bull

glutathione cisplatin Switchable nanoparticles complexing for circumventing depletion in breast cancer chemotherapy Cisplatin - Group 10: platinum
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products